In conclusion, new findings concerning thyroid oncogenes and tumor suppressor genes, as well as studies of growth factors, are starting to explain why patients acquire specific thyroid tumors with different behaviors.


1. Brabant G, Hoang-Vu C, Cetin Y, et al. A differentiation marker in thyroid malignancies. Cancer Res 1993;53:4987.

2. Dremier S, Goldstein J, Mosselmann R, et al. Apoptosis in dog thyroid cells. Biochem Biophys Res Commun 1994;200:52.

3. Coclet J, Fourean F, Ketelbant P, et al. Cell population kinetics in dog and human adult thyroid. Clin Endocrinol (Oxf) 1989;31:655.

4. Dumont JE. The action of thyrotropin on thyroid metabolism. In: Harris RS, Munsen PL, Diczfalusy E, Glover J (eds), Vitamins and Hormones, 29. London. Academic Press, 1971, p 287.

5. Laurent E, Mockel J, Van Sande J, et al. Dual activation by thyrotropin of the phospholipase C and cAMP cascades in human thyroid. Mol Cell Endocrinol 1987:52:273.

6. Parmentier M, Libert F, Maenhaut C, et al. Molecular cloning of the thyrotropin receptor. Science 1989:246:1620.

7. Wynford-Thomas D, Stringer BMJ, Williams ED. Goitrogen-induced thyroid growth in rat: A quantitative morphometric study. J Endocrinol 1982:94:131.

8. Many MC, Denef JF, Haumont S. Precocity of the endothelial proliferation during a course of rapid goitrogenesis. Acta Endocrinol (Copenh) 1984:105:487.

9. Smeds S, Boeryd B, Jôrtsô E, Lennquist S. Normal and stimulated growth of different human thyroid tissues in nude mice. In: Goretzki PE, Rôher HD (eds), Growth Regulation of Thyroid Gland and Thyroid Tumors, Vol 18. Basel, Switzerland, Karger, 1989, p 98.

10. Lewinski A, Bartke A, Smith NKR. Compensatory thyroid hyperplasia in hemithyroidectomized Snell dwarf mice. Endocrinology 1983:113:2317.

11. Roger PP, Servais P, Dumont JE. Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett 1983:157:323.

12. Ambesi-Impiombato FS, Parks LAM, Coon HG. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 1980:77:3455.

13. Westermark K, Karlsson FA, Westermark B. Thyrotropin modulates EGF receptor function in porcine thyroid follicle cells. Mol Cell Endocrinol 1985:40:17.

14. Fayet G, Hovsépian S. Strategy of thyroid cell culture in defined media and the isolation of the Ovnis and Porthos cell strains. In: Eggo MC, Burrow GN (eds), Thyroglobulin: The Prothyroid Hormone. New York, Raven Press, 1985, p 211.

15. Roger PP, Taton M, Van Sande J, Dumont JE. Mitogenic effects of thyrotropin and cyclic AMP in differentiated human thyroid cells in vitro. J Clin Endocrinol Metab 1988;66:1158.

16. Gérard CM, Roger PP, Dumont JE. Thyroglobulin gene expression as a differentiation marker in primary cultures of calf thyroid cells. Mol Cell Endocrinol 1989:61:23.

17. O'Connor MK, Malone JF, Cullen MJ. Long-term cultures of sheep thyroid cells. Acta Endocrinol Suppl (Copenh) 1980:231:5.

18. Heldin NE, Westermark B. Epidermal growth factor, but not thyrotropin, stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture. Endocrinology 1988:122:1042.

19. Westermark B, Karlsson FA, Wâlinder O. Thyrotropin is not a growth factor for human thyroid cells in culture. Proc Natl Acad Sci USA 1979:76:2022.

20. Watanabe Y, Amino N, Tamaki H, et al. Bovine thyrotropin inhibits DNA synthesis inversely with stimulation of cyclic AMP production in cultured porcine thyroid follicles. Endocrinol Jpn 1985:32:81.

21. Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993:365:649.

22. Suarez HG, du Villard JA, Caillou B, et al. gsp mutations in human thyroid tumours. Oncogene 1991:6:677.

23. O'Sullivan C, Barton CM, Staddon SL, et al. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogen 1991;4:345.

24. Ledent C, Dumont JE, Vassart G, Parmentier M. Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 1992; 11:537.

25. Beamer WG, Eicher EM, Maltais LJ, Southard JL. Inherited primary hypothyroidism in mice. Science 1981;212:61.

26. Stein SA, Oates EL, Hall CR, et al. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 1994;8:129.

27. Isler M. Loss of mitotic response of the thyroid gland to TSH in hypophysectomized rats and its partial restoration by anterior and posterior pituitary hormones. Anat Rec 1974;180:369.

28. Bartke A. The response of dwarf mice to murine thyroid-stimulating hormone. Gen Comp Endocrinol 1968:11:246.

29. Westermark K, Westermark B, Karlsson FA, Ericson LE. Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin. Endocrinology 1986;118:1040.

30. Westermark K, Westermark B. Mitogenic effect of epidermal growth factor on sheep thyroid cells in culture. Exp Cell Res 1982;I38:47.

31. Roger PP, Dumont JE. Epidermal growth factor controls the proliferation and the expression of differentiation in canine thyroid cells in primary culture. FEBS Lett 1982;144:209.

32. Westermark K, Karlsson FA, Westermark B. Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology I983;112:1680.

33. Errick JE, Ing KWA, Eggo MC, Burrow GN. Growth and differentiation in cultured human thyroid cells: Effects of epidermal growth factor and thyrotropin. In Vitro 1986;22:28.

34. Gérard CM, Roger PP. Control of proliferation and differentiation in primary cultures of calf thyroid cells. In: Medeiros-Neto G, Gaitan E (eds), Frontiers in Thyroidology, Vol 1. New York, Plenum, 1985, p 345.

35. Duh Q-Y, Gum ET, Râper SE, Clark OH. Epidermal growth factor receptor in normal and neoplastic thyroid tissue. Surgery 1985:98:1000.

36. Kanamori A, Abe Y, Yajima Y, et al. Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. J Clin Endocrinol Metab 1989:68:899.

37. Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic impact of EGF-receptor in papillary thyroid carcinoma. Br J Cancer 1993; 68:808.

38. Mizukami Y, Nonomura A, Michigishi T, et al. Immunohistochemical demonstration of epidermal growth factor receptors in normal, benign and malignant thyroid tissue. Int J Oncol 1992; 1:331.

39. Aasland R, Akslen LA, Varhaug JE, Lillehaug JR. Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid. Int J Cancer 1990:46:382.

40. Tramontano D, Moses AC, Picone R, Ingbar SH. Characterization and regulation of the receptor for insulin-like growth factor-I in the FRTL-5 rat thyroid follicular cell line. Endocrinology 1987:120:785.

41. Bachrach LK, Eggo MC, Hintz RL, Burrow GN. Insulin-like growth factors in sheep thyroid cells: Action, receptors and production. Biochem Biophys Res Commun 1988;154:861.

42. Yashiro T, Tsushima T, Murakami H, et al. Insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptors are increased in primary human thyroid neoplasms. Eur J Cancer 1991 ;27:699.

43. Eggo MC, Bachrach LK, Burrow GN. Role of non-TSH factors in thyroid cell growth. Acta Endocrinol Suppl (Copenh) 1987:281:231.

44. Takahashi SI, Conti M, Van Wyk J. Thyrotropin potentiation of insulinlike growth factor-I dependent deoxyribonucleic acid synthesis in FRTL-5 cells: Mediation by an autocrine amplification factor(s). Endocrinology 1990:126:736.

45. Williams DW, Williams ED, Wynford-Thomas D. Evidence for autocrine production of IGF-I in human thyroid adenomas. Mol Cell Endocrinol 1989;61:139.

46. Minuto F, Barreca A, Del Monte P, et al. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 1989;68:621.

47. Tode B, Serio M, Rotella CM, et al. Insulin-like growth factor-I: Autocrine secretion by human thyroid follicular cells in primary culture. J Clin Endocrinol Metab 1989;69:639.

48. Onoda N, Ohmura E, Tsushima T, et al. Autocrine role of insulin-like growth factor (IGF-1) in a thyroid cancer cell line. Eur J Cancer 1992;28A:1904.

49. Vannelli GB, Barni T, Modigliani U, et al. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990:71:1175.

50. Logan A, Black EG, Gonzalez A-M, et al. Basic fibroblast growth factor: An autocrine mitogen of rat thyroid follicular cells? Endocrinology 1992:130:2363.

51. Greil W, Rafferzeder M, Bechtner G, Gärtner R. Release of an endothelial cell growth factor from cultured porcine thyroid follicles. Mol Endocrinol 1989:3:858.

52. Emoto N, Isozaki O, Arai M, et al. Identification and characterization of basic fibroblast growth factor in porcine thyroids. Endocrinology 1991:128:58.

53. Roger PP, Dumont JE. Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: Effects of thyrotropin, cyclic AMP and growth factors. Mol Cell Endocrinol 1984:36:79.

54. Black EG, Logan A, Davis JRE, Sheppard MC. Basic fibroblast growth factor affects DNA synthesis and cell function and activates multiple signalling pathways in rat thyroid FRTL-5 and pituitary GH3 cells. J Endocrinol 1990:127:39.

55. Pang X-P, Hershman J. Differential effects of growth factors on [3H]thymidine incorporation and [125I]iodine uptake in FRTL-5 rat thyroid cells. Proc Soc Exp Biol Med 1990; 194:240.

56. De Vito WJ, Chanoine J-P, Alex S, et al. Effect of in vivo administration of recombinant acidic fibroblast growth factor on thyroid function in the rat: Induction of colloid goiter. Endocrinology 1992; 131:729.

57. Dremier S, Toton M, Roulonval K, et al. Mitogenic dedifferentiating and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 1994:135:135.

58. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991:6:1997.

59. Di Renzo MF, Olivero M, Ferro S, et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1991;7:2549.

60. Heldin N-E, Gustavsson B, Claesson-Welsh L, et al. Aberrant expression of receptors for platelet-derived growth factor in an anaplastic thyroid carcinoma cell line. Proc Natl Acad Sei USA 1988;85:9302.

61. Heldin N-E, Cvejic D, Smeds S, Westermark B. Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells. Endocrinology 1991;129:2187.

62. Matsuo K, Tang S-H, Sharifi B, et al. Growth factor production by human thyroid carcinoma cells: Abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line. J Clin Endocrinol Metab 1993;77:996.

63. Grubeck-Loebenstein B, Buchan G, Sadeghi R, et al. Transforming growth factor beta regulates thyroid growth. J Clin Invest 1989;83:764.

64. Logan A, Smith C, Becks GP, et al. Enhanced expression of transforming growth factor-beta I during thyroid hyperplasia in rats. J Endocrinol 1994:141:45.

65. Yuasa R, Eggo MC, Meinkoth J, et al. Iodide induces transforming growth factor beta 1 (TGF-beta 1) mRNA in sheep thyroid cells. Thyroid 1992;2:141.

66. Tsushima T, Arai M, Saji M, et al. Effects of transforming growth factor-beta on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 1988:123:1187.

67. Horlocker TT, Hag JE, James EM, et al. Prevalence of incidental nodular thyroid disease detected during high resolution parathyroid ultrasonography. In: Medeiros-Neto GA, Gaitan E (eds), New Frontiers in Thyroidology. New York, Plenum, 1986, p 1309.

68. Studer HK, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth. EndocrRev 1989;10:125.

69. Gerber H, Biirgi U, Peter HJ. Etiology and pathogenesis of thyroid nodules. Exp Clin Endocrinol 1993;101:97.

70. Peter HJ, Gerber H, Studer H, Smeds S. Pathogenesis of heterogeneity in human multinodular goiter: A study on growth and function of thyroid tissue transplanted on to nude mice. J Clin Invest 1985:76:1990.

71. Smeds S, Peter HJ, Jörtsö E, et al. Naturally occurring clones of cells with high intrinsic proliferation potential within the follicular epithelium of mouse thyroids. Cancer Res 1987:47:1646.

72. Goretzki PE, Roher HD. Growth regulation of thyroid gland and thyroid tumours. Front Horm Res I989;18:l.

73. Studer H, Gerber H. Pathogenesis of nontoxic goiter. In: Braverman LE, Utiger R (eds), Werner's and Ingbar's the Thyroid, 6th ed. Philadelphia, JB Lippincott, 1991, p 1107.

74. Fey MF, Peter HJ, Hinds HL, et al. Clonal analysis of human tumors with M27beta, a highly informative polymorphic X-chromosomal probe. J Clin Invest 1992;89:1438.

75. Ramelli F, Studer H, Brugisser D. Pathogenesis of thyroid nodules in multinodular goiter. Am J Pathol 1982; 109:215.

76. Bidey SP. Control of thyroid cell and follicle growth: Recent advances and current controversies. Trends Endocrinol Metab 1990; 1:174.

77. Dumont JE, Maenhaut C, Pirson I, et al. Growth factors controlling the thyroid gland. Baillieres Clin Endocrinol Metab 1991:5:727.

78. Gärtner R. Thyroid growth in vitro. Exp Clin Endocrinol 1992; 100:32.

79. Studer H, Gerber H, Zbären J, Peter HJ. Histomorphological and immuno-histochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab 1992;75:1151.

80. Suärez HG, Duvillard JA, Severino M, et al. Presence of mutations of all three ras genes in human thyroid tumours. Oncogene 1990;5:565.

81. Burn JS, Blaydes JP, Wright PA, et al. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ra.s oncogene: An in vitro model of tumor progression. Carcinogen 1992;6:129.

82. Matsuo K, Tang SH, Fagin JA. Allelotype of human thyroid tumors: Loss of chromosome 11 ql3 sequences in follicular neoplasms. Mol Endocrinol 1991;5:1873.

83. Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992;89:1517.

84. Santoro M, Dathan NA, Berlingieri MT, et al. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994;9:509.

85. Zou M, Shi Y, Farid NR. p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab 1993;77:1054.

86. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocr Rev 1994;15:202.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment